In short: A scalp biopsy is a medical investigation that removes a small skin sample for laboratory analysis. A specialist may consider one when examination does not settle the cause of hair loss, but the result can still be uncertain. Consent, wound care, scarring, infection and the results process should be discussed with the clinic.
A scalp biopsy is one possible investigation when a clinician cannot establish the cause of hair loss from the history and examination alone. It is not a routine requirement for everyone with shedding or thinning. The British Association of Dermatologists says a skin biopsy is very rarely required for suspected telogen effluvium and may be used when the diagnosis is uncertain.
The test provides a skin sample for laboratory examination. That is a different job from looking at the scalp or recording a magnified image, and it does not ensure a definitive answer. The Primary Care Dermatology Society says scalp biopsies are not always needed and sometimes do not provide a definitive diagnosis.
Why a scalp biopsy may be suggested
Hair loss can sometimes be assessed from its distribution, timing, scalp appearance and the person’s wider history. The NHS says a GP may be able to identify the cause by looking at the hair and advises finding out the likely cause before approaching a commercial hair clinic (NHS: Hair loss).
A specialist may consider a biopsy if uncertainty remains after that assessment. The PCDS describes diagnostic uncertainty as the main reason for scalp biopsy, particularly when the outcome could affect clinical management (PCDS: Alopecia overview). A clinician must decide whether that general reason applies to an individual case.
The threshold varies with the clinical question. In its patient information on telogen effluvium, BAD says diagnosis usually rests on the history, scalp examination and a hair-pull test; hairs may also be viewed under a microscope, while a skin biopsy is very rarely required when diagnosis is uncertain (BAD: Telogen effluvium).
A biopsy should therefore answer a defined question. Before agreeing, ask what remains uncertain, what the laboratory will examine and how the possible findings could change the next clinical step. The PCDS says the decision is best left to a specialist who can correlate laboratory findings with the clinical picture (PCDS: Alopecia overview).
How it differs from examination and scalp imaging
A visual examination lets a clinician assess the distribution of loss and visible scalp features. Dermoscopy, which provides a magnified view, is increasingly used to help identify the type of alopecia, according to the PCDS alopecia overview. Those observations remain part of the clinical picture.
A biopsy adds a different kind of evidence. The NHS biopsy guide defines a biopsy as taking a small sample of skin, tissue or cells for testing and says the sample is sent to a laboratory. BAD describes a scalp biopsy in uncertain telogen effluvium cases as a dermatologist taking a small skin sample for laboratory examination (BAD: Telogen effluvium).
A photograph or camera view records surface appearance; laboratory analysis examines the sampled tissue. These sources do not establish that one route replaces the other. The PCDS advises correlating the histology result with clinical findings, which means the sample is interpreted alongside the history and examination rather than in isolation (PCDS: Alopecia overview).
A commercial hair consultation cannot settle the cause of unexplained loss. The NHS advises seeing a GP to get an idea of the cause before visiting a commercial hair clinic (NHS: Hair loss). A transplant enquiry cannot substitute for medical investigation.
Consent and planning before the appointment
A biopsy is an invasive medical test, so consent should come before it. NHS guidance says consent is needed for medical treatment, tests and examinations. Valid consent must be voluntary and informed, with information about what the procedure involves, its benefits and risks, reasonable alternatives and what may happen if it does not go ahead (NHS: Consent to treatment).
That discussion should be specific to the proposed scalp biopsy. Useful points include the clinical question, who will carry out the procedure, the type of sample planned, likely wound closure, expected scarring, local aftercare and how results will be delivered. The general NHS biopsy guidance says the method depends on the body area and biopsy type, and the healthcare team should explain wound care when a dressing or stitches are used.
NHS guidance says an adult with capacity may consent to or refuse a treatment and may withdraw previous consent before the procedure (NHS: Consent to treatment). The clinician can explain whether another investigation is a reasonable alternative and what uncertainty would remain without the sample.
Preparation and aftercare instructions should come from the team performing the biopsy. General webpages and individual hospital leaflets cannot account for the exact site, closure, health history or clinic protocol. The NHS biopsy page directs the doctor or specialist to explain any required preparation and the healthcare team to explain home wound care (NHS: Biopsy).
What the result may and may not settle
The sample goes to a laboratory for testing, after which a doctor or nurse should explain the result and what happens next (NHS: Biopsy). Ask which clinician will combine the laboratory report with the scalp examination and history, because the PCDS says histology should be correlated with clinical findings (PCDS: Alopecia overview).
A result may narrow the possibilities without producing a definitive label. The PCDS states that some scalp biopsies do not provide a definitive diagnosis (PCDS: Alopecia overview). The NHS also notes that another biopsy or other tests are sometimes needed after a biopsy (NHS: Biopsy).
Results timing is clinic-specific. NHS guidance says biopsy results can take a few weeks or more, with waiting times varying between hospitals and according to the reason for the test (NHS: Biopsy). Rather than relying on a universal date, ask the clinic when and how it expects to communicate the report, who to contact if it is delayed and whether a follow-up appointment is included.
Ask the clinician to explain what an uncertain report supports, what it does not settle and whether the working assessment has changed.
Risks and what can go wrong
A scalp biopsy leaves a wound and can leave a scar. An NHS hospital leaflet on skin biopsy describes tenderness, slight bleeding, swelling, bruising, numbness and changes in the early appearance of the scar as possible experiences after the procedure (Chelsea and Westminster Hospital). Its care timings belong to that hospital’s protocol and should not be treated as universal scalp-biopsy instructions.
Infection and bleeding also need discussion. The NHS says infection can occur at a biopsy site and that some biopsy types carry a risk of internal bleeding. It advises urgent contact with the healthcare team or NHS 111 for worsening pain, a high temperature, oozing blood or fluid, swelling or redness after a biopsy (NHS: Biopsy). The hospital leaflet similarly lists persistent bleeding and signs of infection as reasons to seek medical help (Chelsea and Westminster Hospital).
Ask the clinician to explain the likely cosmetic effect before consent, whether hair is expected to cover the area, what wound closure is planned and whom to contact if healing does not follow the clinic’s expected course.
There is also a risk of expecting certainty that the sample cannot provide. The PCDS warns that scalp biopsies are not always needed and can be non-definitive, while the NHS says further tests or another biopsy may sometimes follow (PCDS; NHS). This uncertainty belongs in the consent conversation alongside wound, scar, infection and bleeding risks.
Questions to ask the clinic
- What clinical question is this biopsy intended to answer?
- What did the history, examination or scalp imaging leave uncertain?
- Who will perform the biopsy, and who will analyse the sample?
- What wound, scar, bleeding and infection risks apply in my case?
- What written aftercare instructions will I receive, and whom should I contact about a problem?
- When and how will I receive the result, and is a follow-up appointment included?
- What would happen if the result is uncertain or does not answer the original question?
Talk it through
Once the cause of hair loss has been medically assessed, GetHair can arrange a free consultation with a partner clinic to discuss whether a transplant assessment is relevant. The partner clinic makes clinical decisions and provides any treatment.